Cargando…

Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review

INTRODUCTION: Posttraumatic stress disorder (PTSD) is a psychiatric condition which can be developed following traumatic experience. Treatment guidelines have long considered psychotherapy as a first line treatment. Despite that, PTSD remains an illness with high rates of comorbidity. Therefore, exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sá Couto, J., Da Luz, B., Rodrigues, J., Pão Trigo, M., Ventura Gil, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567883/
http://dx.doi.org/10.1192/j.eurpsy.2022.1730
_version_ 1784809510732300288
author Sá Couto, J.
Da Luz, B.
Rodrigues, J.
Pão Trigo, M.
Ventura Gil, T.
author_facet Sá Couto, J.
Da Luz, B.
Rodrigues, J.
Pão Trigo, M.
Ventura Gil, T.
author_sort Sá Couto, J.
collection PubMed
description INTRODUCTION: Posttraumatic stress disorder (PTSD) is a psychiatric condition which can be developed following traumatic experience. Treatment guidelines have long considered psychotherapy as a first line treatment. Despite that, PTSD remains an illness with high rates of comorbidity. Therefore, exploring novel therapies is of utmost importance. OBJECTIVES: Clarifying methylenedioxymethamphetamine (MDMA)-assisted psychotherapy efficacy in symptom relief in people with PTSD. Explaining clinical MDMA mechanism of action. Assessing safety of MDMA clinical use. METHODS: PubMed database search, with “MDMA for PTSD” keyword expression. 12 Articles published in the last ten years were selected among the 112 best matches. Reference lists of articles were reviewed to identify additional articles. RESULTS: Mithoefer et al. (2010) carried out the first controlled clinical study with MDMA-assisted psychotherapy in people with PTSD. Twenty patients with treatment-resistant PTSD were selected. They were given either placebo or two or three sessions of MDMA. 83% of the experimental group no longer met the criteria for PTSD (mean remission lasted 45 months without further MDMA doses) compared with 25% of the placebo group. Further studies were also suggestive of improvements in treatment-resistant PTSD patients undergoing MDMA-assisted psychotherapy. MDMA may increase exposure therapy effectiveness, allowing patients to stay emotionally involved while revisiting past traumas without being overwhelmed by anxiety and fear. CONCLUSIONS: To date, MDMA-assisted psychotherapy studies demonstrated consistently positive results. However, they have been carried out with small groups of individuals. Therefore, larger trials should be conducted to assess MDMA’s efficacy and safety for it to become a licensed medicine. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9567883
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95678832022-10-17 Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review Sá Couto, J. Da Luz, B. Rodrigues, J. Pão Trigo, M. Ventura Gil, T. Eur Psychiatry Abstract INTRODUCTION: Posttraumatic stress disorder (PTSD) is a psychiatric condition which can be developed following traumatic experience. Treatment guidelines have long considered psychotherapy as a first line treatment. Despite that, PTSD remains an illness with high rates of comorbidity. Therefore, exploring novel therapies is of utmost importance. OBJECTIVES: Clarifying methylenedioxymethamphetamine (MDMA)-assisted psychotherapy efficacy in symptom relief in people with PTSD. Explaining clinical MDMA mechanism of action. Assessing safety of MDMA clinical use. METHODS: PubMed database search, with “MDMA for PTSD” keyword expression. 12 Articles published in the last ten years were selected among the 112 best matches. Reference lists of articles were reviewed to identify additional articles. RESULTS: Mithoefer et al. (2010) carried out the first controlled clinical study with MDMA-assisted psychotherapy in people with PTSD. Twenty patients with treatment-resistant PTSD were selected. They were given either placebo or two or three sessions of MDMA. 83% of the experimental group no longer met the criteria for PTSD (mean remission lasted 45 months without further MDMA doses) compared with 25% of the placebo group. Further studies were also suggestive of improvements in treatment-resistant PTSD patients undergoing MDMA-assisted psychotherapy. MDMA may increase exposure therapy effectiveness, allowing patients to stay emotionally involved while revisiting past traumas without being overwhelmed by anxiety and fear. CONCLUSIONS: To date, MDMA-assisted psychotherapy studies demonstrated consistently positive results. However, they have been carried out with small groups of individuals. Therefore, larger trials should be conducted to assess MDMA’s efficacy and safety for it to become a licensed medicine. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567883/ http://dx.doi.org/10.1192/j.eurpsy.2022.1730 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Sá Couto, J.
Da Luz, B.
Rodrigues, J.
Pão Trigo, M.
Ventura Gil, T.
Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title_full Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title_fullStr Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title_full_unstemmed Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title_short Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
title_sort methylenedioxymethamphetamine-assisted psychotherapy for posttraumatic stress disorder: a review
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567883/
http://dx.doi.org/10.1192/j.eurpsy.2022.1730
work_keys_str_mv AT sacoutoj methylenedioxymethamphetamineassistedpsychotherapyforposttraumaticstressdisorderareview
AT daluzb methylenedioxymethamphetamineassistedpsychotherapyforposttraumaticstressdisorderareview
AT rodriguesj methylenedioxymethamphetamineassistedpsychotherapyforposttraumaticstressdisorderareview
AT paotrigom methylenedioxymethamphetamineassistedpsychotherapyforposttraumaticstressdisorderareview
AT venturagilt methylenedioxymethamphetamineassistedpsychotherapyforposttraumaticstressdisorderareview